Skip to content
Top Globe News – Lifestyle
Author:
3H Pharmaceuticals
Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences’ Zhou Jian Comments on Potential for Patients With FGFR2 Alterations
June 2, 2026